Detalles de la búsqueda
1.
Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias.
Am J Ther
; 30(1): e56-e71, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36048531
2.
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis.
Am J Ther
; 30(1): e36-e55, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36608071
3.
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Cochrane Database Syst Rev
; 9: CD015048, 2022 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161421
4.
Maintaining surgical care delivery during the COVID-19 pandemic: A comparative cohort study at a tertiary gynecological cancer centre.
Gynecol Oncol
; 160(3): 649-654, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358197
5.
Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?
J Obstet Gynaecol
; 40(6): 849-855, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31933417
6.
Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy.
Arch Gynecol Obstet
; 300(5): 1261-1270, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31414175
7.
Reporting 'Denominator' data is essential for benchmarking and quality standards in ovarian cancer.
Gynecol Oncol
; 146(1): 94-100, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28411948
8.
Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer.
J Obstet Gynaecol
; 37(8): 1070-1075, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28741395
9.
Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study.
Int J Gynecol Cancer
; 25(9): 1599-607, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26397157
10.
Surgical cytoreduction for recurrent epithelial ovarian cancer.
Cochrane Database Syst Rev
; (2): CD008765, 2013 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23450588
11.
Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.
Gynecol Oncol
; 124(1): 142-7, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22001143
12.
Serum Albumin as a Predictor of Survival after Interval Debulking Surgery for Advanced Ovarian Cancer (AOC): A Retrospective Study.
J Invest Surg
; 35(2): 426-431, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33021127
13.
Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis.
BMJ Open
; 12(8): e060183, 2022 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36038183
14.
Optimal primary surgical treatment for advanced epithelial ovarian cancer.
Cochrane Database Syst Rev
; (8): CD007565, 2011 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21833960
15.
The evolving role of one-step nucleic acid amplification (OSNA) for the intra-operative detection of lymph node metastases: A diagnostic accuracy meta-analysis.
Eur J Surg Oncol
; 47(6): 1233-1243, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33309549
16.
A comparative study between the Universal Spinal System® (USS) and the CD Horizon® Legacy™ (CDH) in the management of thoracolumbar fractures.
SICOT J
; 5: 42, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31782725
17.
Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer.
Eur J Surg Oncol
; 44(6): 760-765, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29426779
18.
Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention.
Eur J Obstet Gynecol Reprod Biol
; 226: 47-53, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29807350
19.
The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis.
PLoS One
; 9(6): e90604, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24603616
20.
Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survival.
Cancer Res
; 72(22): 5675-82, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23066035